The SARS-CoV-2 high infectivity is due to the functional polybasic furin cleavage site in the S protein. How it was acquired is unknown. There are two challenges to face: (i) an evolutionary model, to fit the origin of the coronavirus; and (ii) a molecular mechanism for the site
Here we show genomic fingerprints which are specific of Pangolin-CoVs, Bat-SARS-like (CoVZC45, CoVZXC21), bat RatG13 and human SARS-CoV-2 coronaviruses.
This, along with phylogenetic analysis, we found that these species have the same evolutionary origin in the bat, including a genetic recombination of S gene between Pangolin-CoV (2017) and RatG13 ancestors.
However, this does not explain why SARS-CoV-2 is the only of them with the furin site, which consists in four amino acid (PRRA) motif. The Arginine doublet is encoded by CGGCGG codons.
Surprisingly, none of the Arginine doublet of other furin site of viral proteins from several type of viruses, are encoded by the CGGCGG codons.
Taken together, all these lines of evidence and reasoning show that the acquisition of the polybasic furin cleavage site by SARS-CoV-2 is a “missing link” in our understanding of its evolutionary history, that can only be addressed through the discovery of new viruses.
"Nothing in Biology Makes Sense Except in the Light of Evolution" becomes more relevant in the case of the pandemic virus, not only because there is the hypothesis of a laboratory origin, but also because there is a furin site that has changed the world.
This paper concludes that the Furin Cleavage Site of SARS CoV 2 at the junction of S1/S2 of its Spike Protein which makes it more infectious has mysterious origin & its the missing link in its evolutionary theory. Hinting at the lab leak theory !
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Summary of Various studies on Vaccines & on various strains of SARS-Cov-2 :
Original SARS-CoV-2 strain from Wuhan
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection - Nature Peer reviewed study of 17th May 2021
Nature Study on Original Wuhan Strain of SARS-CoV-2
>Novovax (Protein Sub Unit Vax Tops) - 98%
> Pfizer & Moderna - 95% after 2 Doses
> Sputnik - 95% 2 Doses
> COVAXIN - 80% 2 Doses
> AstraZeneca- 78% {2 doses after 8 weeks, post 12 weeks 90%]
> SINOVAC - 55% after 2 Doses
first dose of ChAdOx1 was found to be associated with small increased risks of ITP, with suggestive evidence of an increased risk of arterial thromboembolic and hemorrhagic events.
The attenuation of effect found in the SCCS analysis means that there is the potential for overestimation of the reported results, which might indicate the presence of some residual confounding or confounding by indication.
Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine (COVAXIN) biorxiv.org/content/10.110…
The two-dose vaccine regimen significantly boosted the IgG titer and neutralizing efficacy against both B.1.1.28.2 and D614G variants compared to that seen with natural infection.
The study demonstrated 1.92 and 1.09 fold reductions in the neutralizing titer against B.1.1.28.2 variant in comparison with prototype D614G variant with sera of vaccine recipients and natural infection respectively.
Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 - COVAXIN biorxiv.org/content/10.110…
Several studies have demonstrated the reduction in the naturalisation efficacy of the SERA of naturally infected and individuals vaccinated with BBIP-CorV (1.6x) - Sinopharm, BNT162b2 (6.5X) - Pfizer, m-RNA1273 (8.6X) - Moderna, ChAdOx1 nCOV (86X) - COVIDSHIELD against B.1.351.
Reduced Naturalisation with the Vaccine Sera of BNT162b2 mRNA (7X) & one dose of ChAdOx1 nCov-19 was observed against B.1.617.2 Delta Variant.
Whereabouts of two scientists fired from Winnipeg virus lab for possible national-security issues shrouded in mystery headtopics.com/ca/whereabouts…
Four months before the couple was expelled from the lab, access-to-information documents show that Dr. Qiu played a key role in shipping two exceptionally virulent viruses – Ebola and Henipah – to China’s Wuhan facility.
The decision to grant access is made by the Public Health Agency of Canada,” CSIS spokesperson Keira Lawson said in an e-mail.Dr. Qiu’s name appears as a co-author on more than 120 scientific research papers between 2000 and 2021.
Are u a Virologist. Are u Biologist. Are u a Vaccineologists. I am an educated person who have read extensively read research papers on SARS COV 2 as well as Vaccine Trials and i state on TL various researches. As discussed o. space even doctors appreciated the effort put on TL.
Also one day u find study saying COVIDSHIELD better response than COVAXIN, other day there was Nature Medical Journal Article stating reverse. The other day we hear studies on how Spike Protein based Vaccines get neutralised on Mutants & need constant upgrades.
I share Various research on my TL. I was even advised by learned people to continue this trend & disseminate scientific information, while stating limitations, conflict of interest which is so stated in every Vaccine study to give a correct perspective. Rest is upto readers.